Jim Zhen Wu

2.7k total citations
50 papers, 2.1k citations indexed

About

Jim Zhen Wu is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jim Zhen Wu has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Jim Zhen Wu's work include Hepatitis C virus research (22 papers), Biochemical and Molecular Research (13 papers) and HIV/AIDS drug development and treatment (13 papers). Jim Zhen Wu is often cited by papers focused on Hepatitis C virus research (22 papers), Biochemical and Molecular Research (13 papers) and HIV/AIDS drug development and treatment (13 papers). Jim Zhen Wu collaborates with scholars based in United States, China and Norway. Jim Zhen Wu's co-authors include Zhi Hong, Gary Larson, Nanhua Yao, Shunqi Yan, T.C. Appleby, Jae Hoon Shim, Robert Hamatake, Weidong Zhong, Zhi Hong and I. Wayne Cheney and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Cell.

In The Last Decade

Jim Zhen Wu

50 papers receiving 2.0k citations

Peers

Countries citing papers authored by Jim Zhen Wu

Since Specialization

Citations

This map shows the geographic impact of Jim Zhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Zhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Zhen Wu more than expected).

Fields of papers citing papers by Jim Zhen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Zhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Zhen Wu. The network helps show where Jim Zhen Wu may publish in the future.

Co-authorship network of co-authors of Jim Zhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Zhen Wu. A scholar is included among the top collaborators of Jim Zhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Zhen Wu. Jim Zhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of antiviral resistance across acute and chronic viral infections 2018 ·Antiviral Research ·Stephen W. Mason, John P. DeVincenzo, Stephen Toovey, Jim Zhen Wu, Richard J. Whitley	54
2	Polo-like Kinase Inhibitor Ro5203280 Has Potent Antitumor Activity in Nasopharyngeal Carcinoma 2013 ·Molecular Cancer Therapeutics ·Arthur Kwok Leung Cheung, (unknown), Hong Lok Lung, Jim Zhen Wu, Sai Wah Tsao, Maria Li Lung	14
3	Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol 2013 ·Bioorganic & Medicinal Chemistry Letters ·Shoujun Chen, Lijun Sun, Keizo Koya, Noriaki Tatsuta, Zhiqiang Xia, Timothy Korbut, Zhenjian Du, Jim Zhen Wu, Guiqing Liang, Jun Jiang, Mitsunori Ono, Dan Zhou, Andrew J. Sonderfan	43
4	Identification and Characterization of Multiple TRIM Proteins That Inhibit Hepatitis B Virus Transcription 2013 ·PLoS ONE ·Shijian Zhang, Ju‐Tao Guo, Jim Zhen Wu, Guang Yang	45
5	The Molecular Basis of ABA-Independent Inhibition of PP2Cs by a Subclass of PYL Proteins 2011 ·Molecular Cell ·Qi Hao, Ping Yin, Wenqi Li, Lı Wang, Chuangye Yan, Zhaohu Lin, Jim Zhen Wu, Jiawei Wang, S. Frank Yan, Nieng Yan	225
6	Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin 2011 ·PLoS ONE ·Lei Zhu, Yuhuan Li, Shaohua Li, Haodong Li, Zongxing Qiu, (unknown), Henry Horng‐Shing Lu, Xianfeng Lin, Rong Zhao, Li Chen, Jim Zhen Wu, Guozhi Tang, Wengang Yang	47
7	Discovery of novel 1-phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Guozhi Tang, Zongxing Qiu, Xianfeng Lin, Wentao Li, Lei Zhu, Shaohua Li, Haodong Li, Lisha Wang, Li Chen, Jim Zhen Wu, Wengang Yang	13
8	Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: An ontogenic study 2008 ·Epilepsia ·Andréy Mazarati, Jim Zhen Wu, Don Shin, Young Se Kwon, Raman Sankar	33
9	Identification and Structure—Activity Relationships of Substituted Pyridones as Inhibitors of Pim‐1 Kinase. 2007 ·ChemInform ·I. Wayne Cheney, Shunqi Yan, T.C. Appleby, (unknown), Todd Vo, Nanhua Yao, Robert Hamatake, Zhi Hong, Jim Zhen Wu	4
10	Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinase 2007 ·Bioorganic & Medicinal Chemistry Letters ·I. Wayne Cheney, Shunqi Yan, T.C. Appleby, (unknown), Todd Vo, Nanhua Yao, Robert Hamatake, Zhi Hong, Jim Zhen Wu	148
11	Structure–activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Shunqi Yan, Gary Larson, Zhi Hong, Jim Zhen Wu	99
12	Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure 2006 ·Bioorganic & Medicinal Chemistry Letters ·Shunqi Yan, Gary Larson, Jim Zhen Wu, T.C. Appleby, Yili Ding, Robert Hamatake, (unknown), Nanhua Yao	46
13	Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Dinesh A. Barawkar, (unknown), Subrata Chakravarty, Matthew Allan, Huanming Chen, Weijian Zhang, Jim Zhen Wu, Robert C. Tam, Robert Hamatake, Stanley A. Lang, Zhi Hong	32
14	Isothiazoles as active-site inhibitors of HCV NS5B polymerase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Shunqi Yan, T.C. Appleby, Esmir Gunić, Jae Hoon Shim, (unknown), (unknown), (unknown), (unknown), Robert Hamatake, Jim Zhen Wu, Zhi Hong, Nanhua Yao	39
15	Identification of isothiazole-4-carboxamidines derivatives as a novel class of allosteric MEK1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Dinesh A. Barawkar, Subrata Chakravarty, Andreas Maderna, Robert C. Tam, Huanming Chen, (unknown), Jim Zhen Wu, T.C. Appleby, Shunqi Yan, Weijian Zhang, Stanley A. Lang, Nanhua Yao, Robert Hamatake, Zhi Hong	20
16	Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase 2005 ·Bioorganic Chemistry ·Yili Ding, Jean‐Luc Girardet, Kenneth L. Smith, Gary Larson, Brett J. Prigaro, Jim Zhen Wu, Nanhua Yao	49
17	Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Yili Ding, Jean‐Luc Girardet, Kenneth L. Smith, Gary Larson, Brett J. Prigaro, Vicky C. H. Lai, Weidong Zhong, Jim Zhen Wu	28
18	Canonical 3′-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase 2003 ·Antiviral Research ·(unknown), (unknown), Vicky C. H. Lai, (unknown), Jim Zhen Wu	41
19	Crystal Structure of Tritrichomonas foetus Inosine Monophosphate Dehydrogenase in Complex with the Inhibitor Ribavirin Monophosphate Reveals a Catalysis-dependent Ion-binding Site 2002 ·Journal of Biological Chemistry ·Glen L. Prosise, Jim Zhen Wu, Hartmut Luecke	34
20	Internally Located Signal Peptides Direct Hepatitis C Virus Polyprotein Processing in the ER Membrane 2001 ·IUBMB Life ·Jim Zhen Wu	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact